For the Inventor, By the Inventor

Enter assignee name

Durham, NC, United States of America

Icagen, Inc.

USPTO Granted Patents = 102

% Expired Patents = 55.9

CIPO Patents = 5

EPO Patents = 26

Trademarks = 4

Forward Citations = 551

Loading Chart...

Loading Chart...

95 inventors (with patents filed for the assignee):

Timothy James Jegla (24 out of 24 patents)

Michael F Gross (20 out of 28 patents)

Benjamin P Warner (17 out of 46 patents)

4. Serge Beaudoin (15 out of 16 patents)

5. Grant Andrew McNaughton-Smith (14 out of 14 patents)

6. Brian Edward Marron (13 out of 37 patents)

7. Xiaodong Wang (12 out of 37 patents)

8. Alan Bradley Fulp (12 out of 15 patents)

9. Lori J Peterson (11 out of 14 patents)

10. Alan David Wickenden (11 out of 12 patents)

11. George Salvatore Amato (10 out of 11 patents)

12. Mark J Suto (9 out of 36 patents)

13. Nathan H Zahler (9 out of 10 patents)

14. Jennifer A Berger (9 out of 13 patents)

15. Eva Rachel Birnbaum (9 out of 20 patents)

Core Competencies:

Potassium Channel

X-ray Fluorescence

Analyte Detection

Protein Modification

Ion Channel Inhibitors

Sulfonamide Compounds

Heterocycles

Calcium Channel Antagonists

Cyclic Nucleotide-Gated Channels

Fused Ring Heterocycles

Sodium Channel Inhibitors

Polycyclic Compounds

102 patents: Sort by Forward Citations

1. 12703697 - BCAT modulation (2026-08-11),

2. 11639941 - Methods for measuring analyte transport across barriers using X-ray fluorescence (2023-05-02),

3. 11598759 - Sensors and sensor arrays for detection of analytes (2023-03-07),

4. 11573224 - Methods of detection using X-ray fluorescence (2023-02-07),

5. 11561188 - Method and apparatus for measuring protein post-translational modification (2023-01-24),

6. 10948437 - Method for analysis using X-ray fluorescence (2021-03-16),

7. 10877035 - Advanced drug development and manufacturing (2020-12-29),

8. 10782253 - Well plate (2020-09-22),

9. 10577642 - Method and apparatus for measuring protein post-translational modification (2020-03-03),

10. 10527600 - Sensors and sensor arrays for detection of analytes (2020-01-07),

11. 10458933 - Method for analysis using X-ray fluorescence (2019-10-29),

12. 10082511 - Methods for measuring analyte transport across barriers using X-ray fluorescence (2018-09-25),

13. 10082474 - Method for analysis using X-ray fluorescence (2018-09-25),

14. 9976172 - Method and apparatus for measuring protein post-translational modification (2018-05-22),

15. 9506931 - Method for measuring analyte transport across cell membranes using X-ray fluorescence (2016-11-29),

Company Overview

Icagen, Inc., based in Durham, NC, specializes in the development of innovative potassium channel modulators aimed at addressing various medical conditions. The company focuses on advanced technologies such as X-ray fluorescence and analyte detection, enhancing its capabilities in protein modification and the design of ion channel inhibitors. With a strong emphasis on sulfonamide compounds and heterocycles, Icagen is at the forefront of research in calcium channel antagonists, contributing significantly to the field of pharmacology and therapeutic solutions.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 20 2026

102 Patents

#12 in Durham, NC

#97 in North Carolina

#3,725 in US

#7,654 in the World

Durham, NC, United States of America

Icagen, Inc.

Forward Citations = 551

95 inventors:

Timothy James Jegla (24 out of 24 patents)

Michael F Gross (20 out of 28 patents)

Benjamin P Warner (17 out of 46 patents)

4. Serge Beaudoin (15 out of 16 patents)

5. Grant Andrew McNaughton-Smith (14 out of 14 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Icagen, Inc.. Retrieved from https://idiyas.com/company/icagen

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

Loading…